Ann: Ceasing to be a substantial holder, page-10

My sentiment has changed - still holding, but no longer consider mysekf a true believer - as I think that the latest Newsletter was a sad rehash of everything we already knew - and with the nonsense claim of a 50% price rise.........nothing new to read I am afraid.

Talk about blowing smoke somewhere dark.

The share price rise was essentially off multi year lows - so it is hardly a news item worth bragging about - especially since it has retreated 20% from the recent five nanosecond high.

It is not as if there is any certainty that these PTSD results will be more than another demonstration that BNC 210 does not have adverse side effects. ie the patients did not die or grow a second head.

Inconclusive results in relation to efficacy will be enough for everyone else to joint the chorus and to say "enough!!!".

Moving on to yet another trial for BNC 210 (for agitation) is just management covering their own back and side - in the event that the PTSD trial misses it objectives.

The delay in inking a deal on the oncology assets suggests that the price is going to underwhelm everyone..........

GLTA - we will need it.